CLIAC Workgroups

Banner image of CLIAC workgroups

The Clinical Laboratory Improvement Advisory Committee (CLIAC) may convene workgroups to discuss issues and gather information on specific topics related to matters identified through Committee discussions or as outlined in the CLIAC Charter. The output of the workgroup will be a summary report based on research activities and information gathered during workgroup discussions.  

Workgroup reports are presented at future CLIAC meetings for Committee discussion, deliberation, and potential recommendations to the Secretary, Department of Health and Human Services (HHS); the Assistant Secretary for Health, HHS; the Director, Centers for Disease Control and Prevention (CDC); the Commissioner, Food and Drug Administration (FDA); and the Administrator, Centers for Medicare & Medicaid Services (CMS).  

The advice and guidance from CLIAC pertain to issues related to improvement in clinical laboratory quality and laboratory medicine and specific questions related to possible revisions of the Clinical Laboratory Improvement Amendments of 1988 (CLIA) standards. 


You can find summaries of past meetings that contain information about CLIAC workgroup activities on our website.  

Contact CLIAC